E COLI VIRULENCE TRAITS IN INTRAABDOMINAL INFECTION

腹内感染中的大肠杆菌毒力特征

基本信息

  • 批准号:
    3455408
  • 负责人:
  • 金额:
    $ 10.67万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1990
  • 资助国家:
    美国
  • 起止时间:
    1990-02-01 至 1995-01-31
  • 项目状态:
    已结题

项目摘要

In spite of advances in surgical techniques, critical care facilities, diagnostic capacities, and improvements in antimicrobial therapy, the mortality from intraabdominal infection remains high. A recent experience from five university intensive care units reported an overall mortality of 28% from intraabdominal infection. The magnitude of the clinical problem necessitates continued basic research. The peritoneal cavity possesses a remarkable capacity to combat infection. Surgical predecessors have laid the groundwork of defining the mechanics whereby this region of the body handles infection. These are typically described as: a) rapid dispersal of particulate matter (including bacteria) via diaphragmatic lymphatics lacunae; b) rapid upregulation of phagocytic capacity within the peritoneum within 2-6 hours after bacterial introduction; and c) mechanical sequestration of bacteria by fibrin trapping and obliteration of dead space by paralytic ileus. An important consideration missing from the majority of these studies is the alteration in outcome predicated upon rapid adaptive changes of the infecting organisms. All bacteria do not possess the same ability to produce infection and many can undergo significant phenotypic changes in different environments. The specific aim of this proposal is to understand how the most frequently recovered bacteria from intraabdominal infection, Escherichia coli, evolves during peritoneal infection. These organisms are not inert, but actively change their metabolic pathways and physical properties to survive in a hostile environment. The goals of the project are to determine: 1) the intraperitoneal kinetics of varying wild types and laboratory strains of E. coli, and correlate known virulence traits (O and K antigens, alpha-hemolysin production, ability to adhere to mammalian cells, and the expression of outer membrane proteins) to survivability within the peritoneum. 2) the effect of adjuvants of intraperitoneal infection (hemoglobin, bile salts, stool, mucin) upon the infectivity of E. coli and correlation with virulence. 3) the traits of E. coli which promote mixed infections: in particular with the most common anaerobe, Bacteroides fragilis. An improved prognosis for patients with intraabdominal infection will occur when physicians understand not only the manner in which the host defenses interact with infecting organisms, but also the adaptive mechanisms employed by the bacteria to survive within the host peritoneum. It is the purpose of this proposal to begin the process of delineating these mechanisms.
尽管外科技术进步了,重症监护设施,

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TIMOTHY L PRUETT其他文献

TIMOTHY L PRUETT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TIMOTHY L PRUETT', 18)}}的其他基金

PHARMACOKINETICS OF ABBOTT CYCLOSPORINE FOLLOWING LIVER TRANSPLANT
肝移植后雅培环孢素的药代动力学
  • 批准号:
    6579037
  • 财政年份:
    2002
  • 资助金额:
    $ 10.67万
  • 项目类别:
PHARMACOKINETIC COMPARISON OF NEORAL TO ABBOTT CYCLOSPORINE
NEORAL 与雅培环孢素的药代动力学比较
  • 批准号:
    6578935
  • 财政年份:
    2002
  • 资助金额:
    $ 10.67万
  • 项目类别:
PHARMACOKINETICS OF ABBOTT CYCLOSPORINE FOLLOWING LIVER TRANSPLANT
肝移植后雅培环孢素的药代动力学
  • 批准号:
    6477564
  • 财政年份:
    2001
  • 资助金额:
    $ 10.67万
  • 项目类别:
PHARMACOKINETIC COMPARISON OF NEORAL TO ABBOTT CYCLOSPORINE
NEORAL 与雅培环孢素的药代动力学比较
  • 批准号:
    6477462
  • 财政年份:
    2001
  • 资助金额:
    $ 10.67万
  • 项目类别:
PHARMACOKINETIC COMPARISON OF NEORAL TO ABBOTT CYCLOSPORINE
NEORAL 与雅培环孢素的药代动力学比较
  • 批准号:
    6307416
  • 财政年份:
    1999
  • 资助金额:
    $ 10.67万
  • 项目类别:
PHARMACOKINETIC COMPARISON OF NEORAL TO ABBOTT CYCLOSPORINE
NEORAL 与雅培环孢素的药代动力学比较
  • 批准号:
    6265268
  • 财政年份:
    1998
  • 资助金额:
    $ 10.67万
  • 项目类别:
IV HBIG PHARMACOKINETIC STUDY
IV HBIG 药代动力学研究
  • 批准号:
    6279433
  • 财政年份:
    1997
  • 资助金额:
    $ 10.67万
  • 项目类别:
SAFETY OF ORAL GANCICLOVIR IN THE PREVENTION OF CYTOMEGALOVIRUS DISEASE
口服更昔洛韦预防巨细胞病毒病的安全性
  • 批准号:
    6279423
  • 财政年份:
    1997
  • 资助金额:
    $ 10.67万
  • 项目类别:
E COLI VIRULENCE TRAITS IN INTRAABDOMINAL INFECTION
腹内感染中的大肠杆菌毒力特征
  • 批准号:
    3455409
  • 财政年份:
    1990
  • 资助金额:
    $ 10.67万
  • 项目类别:
E COLI VIRULENCE TRAITS IN INTRA-ABDOMINAL INFECTION
腹内感染中的大肠杆菌毒力特征
  • 批准号:
    2064751
  • 财政年份:
    1990
  • 资助金额:
    $ 10.67万
  • 项目类别:

相似国自然基金

asr基因调控酸诱导的Escherichia coli O157:H7形成VBNC状态的机制研究
  • 批准号:
    32302245
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
小肠中Escherichia coli分泌细菌毒素诱导肠屏障损伤及细菌易位在炎症性肠病中的机制研究
  • 批准号:
    82371775
  • 批准年份:
    2023
  • 资助金额:
    46 万元
  • 项目类别:
    面上项目
基于Escherichia coli O157:H7亚致死态细胞探究超高压与原儿茶酸协同杀菌机制
  • 批准号:
    31871817
  • 批准年份:
    2018
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目
肠肝轴:从临床患者分离的肠道致病菌株Escherichia coli NF73-1对非酒精性脂肪性肝病的作用及机制研究
  • 批准号:
    81873549
  • 批准年份:
    2018
  • 资助金额:
    57.0 万元
  • 项目类别:
    面上项目
高压二氧化碳诱导Escherichia coli O157:H7形成VBNC状态的分子机制
  • 批准号:
    31571933
  • 批准年份:
    2015
  • 资助金额:
    57.0 万元
  • 项目类别:
    面上项目
超高压诱导牛肉中Escherichia coli O157:H7亚致死损伤及其修复研究
  • 批准号:
    31371861
  • 批准年份:
    2013
  • 资助金额:
    15.0 万元
  • 项目类别:
    面上项目
高压二氧化碳诱导Escherichia coli O157:H7形成VBNC状态的机制
  • 批准号:
    31371845
  • 批准年份:
    2013
  • 资助金额:
    15.0 万元
  • 项目类别:
    面上项目
高密度二氧化碳致死Escherichia coli的相关蛋白质确证及其结构变化研究
  • 批准号:
    31171774
  • 批准年份:
    2011
  • 资助金额:
    66.0 万元
  • 项目类别:
    面上项目

相似海外基金

Knowledgebase of Escherichia coli Genome and Metabolism
大肠杆菌基因组和代谢知识库
  • 批准号:
    10716050
  • 财政年份:
    2023
  • 资助金额:
    $ 10.67万
  • 项目类别:
Copper Sensing in Uropathogenic Escherichia coli
尿路致病性大肠杆菌中的铜感应
  • 批准号:
    10604449
  • 财政年份:
    2023
  • 资助金额:
    $ 10.67万
  • 项目类别:
Investigating metabolism and DNA damage repair in uropathogenic Escherichia coli fluoroquinolone persisters
研究泌尿道致病性大肠杆菌氟喹诺酮类持续存在的代谢和 DNA 损伤修复
  • 批准号:
    10747651
  • 财政年份:
    2023
  • 资助金额:
    $ 10.67万
  • 项目类别:
Inactivation of Escherichia coli using high hydrostatic pressure from viewpoints of cell shrinkage and expansion
从细胞收缩和扩张的角度利用高静水压灭活大肠杆菌
  • 批准号:
    23K05105
  • 财政年份:
    2023
  • 资助金额:
    $ 10.67万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Metabolic engineering of Escherichia coli for carbon capture and hydrogen storage.
用于碳捕获和氢储存的大肠杆菌代谢工程。
  • 批准号:
    2869802
  • 财政年份:
    2023
  • 资助金额:
    $ 10.67万
  • 项目类别:
    Studentship
Development of new removal method targeting Escherichia coli causing colorectal cancer
开发针对引起结直肠癌的大肠杆菌的新去除方法
  • 批准号:
    23K19489
  • 财政年份:
    2023
  • 资助金额:
    $ 10.67万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Structural Determinants of Permeation Barriers in Escherichia coli
大肠杆菌渗透屏障的结构决定因素
  • 批准号:
    10749251
  • 财政年份:
    2023
  • 资助金额:
    $ 10.67万
  • 项目类别:
Development of rotavirus-based enterotoxigenic Escherichia coli dual vaccines
基于轮状病毒的产肠毒素大肠杆菌双重疫苗的研制
  • 批准号:
    10741541
  • 财政年份:
    2023
  • 资助金额:
    $ 10.67万
  • 项目类别:
A novel genetic switch with an optimal ON/OFF ratio to preserve growth performance prior to Escherichia coli autolysis for enhanced plasmid release
一种具有最佳开/关比的新型基因开关,可在大肠杆菌自溶之前保持生长性能,从而增强质粒释放
  • 批准号:
    2881246
  • 财政年份:
    2023
  • 资助金额:
    $ 10.67万
  • 项目类别:
    Studentship
DEVELOPMENT OF IN VITRO DIAGNOSTICS FOR ANTIMICROBIAL RESISTANCE ESCHERICHIA COLI
大肠杆菌耐药性体外诊断的开发
  • 批准号:
    10912990
  • 财政年份:
    2023
  • 资助金额:
    $ 10.67万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了